Keyrus Life Science, the Connected-CRO (C2RO), strengthens its synergies with the Keyrus Group, adopting a new visual identity and deploying a complete portfolio of services to drive clinical research forward
28 Jun 2022
LEVALLOIS-PERRET, France, June 28, 2022 /PRNewswire/ --
Keyrus
Life Science announces the launch of its new visual identity strengthening its synergies with the
Keyrus Group to address the most pressing challenges of its clients in the life science industry and to
drive clinical research forward.
"The development of
Keyrus Life Science is based on the premise that it is only by giving meaning to data as quickly as possible that mankind can successfully tackle the major existing and emerging health issues", declares
Michael Attlan, VP, Head of Life Science Innovation & Strategic Engagements. "Keyrus Life Science is a unique Connected-CRO that enhances the performance, the speed and the agility of clinical trials by making data matter."
Relying on a strong scientific background built from the combined international expertise of 300 consultants and 25 years of experience,
Keyrus Life Science connects in-depth industry know-how, life data sciences and digital enablement. It fully leverages both clinical research ecosystems and Real-World Evidence (RWE), thus enhancing the
reliability, innovative capacity, agility, and, above all,
speed of execution of clinical research activities.
Keyrus Life Science unlocks for its clients the means to achieve digitalization across all life science industry segments and throughout all phases of the R&D cycle, from the earliest clinical stages, through to real world evidence and insights in a post-marketing setting.
By capitalizing on digital technologies, data sciences and honed industry expertise,
Keyrus Life Science creates a
unique value proposition, driven by innovation, passion and scientific rigor.
Keyrus Life Science accompanies its clients in:
Framing their clinical development strategies
Operationalizing their clinical development
Implementing RWE and late phase projects
Enabling life data science boosters
Reaching the next level in digital innovation
"
Keyrus Life Science fits into the
Keyrus Group's vision and shares both its values, and its keen innovative spirit", declares
Eric Cohen, CEO of Keyrus. "Drawing upon highly original ways of using and valorizing health data,
Keyrus Life Science's proposition is unique in the market today. Combined with the
Keyrus Group's longstanding data-digital expertise,
Keyrus Life Science's offerings thus bring innovative and concrete solutions to companies in this sector and support them in reinventing their clinical research strategy."
ABOUT KEYRUS
An international player in the consulting and technology sectors and a specialist in data and digital technology,
Keyrus is dedicated to helping enterprises take advantage of the data and digital paradigm to enhance their performance, facilitate and accelerate their transformation, and generate new drivers of growth and competitiveness.
Placing innovation at the heart of its strategy,
Keyrus develops a value proposition that is unique in the market and centred around five major service groups, each comprised of multiple solutions:
Automation and Artificial Intelligence
Human-Centric Digital Experience
Data and Analytics enablement
Cloud and Security
Business transformation and Innovation
Building on the combined expertise of more than 3,000 employees active across 22 countries and 4 continents,
Keyrus is one of the leading international experts in data, consulting and technology.
Further information at: www.keyrus.com
Contact :LA NOUVELLE AGENCE, Elvin Macko, [email protected]
KEYRUS, Catherine Squires, [email protected]
Logo - https://mma.prnewswire.com/media/1659746/Keyrus_Logo.jpg
SOURCE Keyrus
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.